Indeed, given that NKX3.1 maps to a key region of the chromosome, 8p21, that undergoes allelic loss in up to 80% of early-stage prostate cancer cases, incorporating analyses of inflammation status combined with NKX3.1 status may enhance models for risk assessment of prostate cancer in a precision cancer-prevention context. This evidence concerns the gene NKX3-1 and cancer.